Revenue | ₹49.57Cr |
Net Profits | ₹-7.35Cr |
Net Profit Margins | -14.83% |
Mangalam Drugs and Organics Ltd’s revenue fell -38.1% since last year same period to ₹49.57Cr in the Q2 2025-2026. On a quarterly growth basis, Mangalam Drugs and Organics Ltd has generated -13.57% fall in its revenue since last 3-months.
Mangalam Drugs and Organics Ltd’s net profit fell -373.23% since last year same period to ₹-7.35Cr in the Q2 2025-2026. On a quarterly growth basis, Mangalam Drugs and Organics Ltd has generated 46.74% jump in its net profits since last 3-months.
Mangalam Drugs and Organics Ltd’s net profit margin fell -541.41% since last year same period to -14.83% in the Q2 2025-2026. On a quarterly growth basis, Mangalam Drugs and Organics Ltd has generated 38.38% jumped in its net profit margins since last 3-months.
The revenue for Mangalam Drugs and Organics Ltd in the Q2 results 2025 was ₹49.57Cr.
The net profit for Mangalam Drugs and Organics Ltd in the Q2 results 2025 was ₹-7.35Cr.
The net profit margin for Mangalam Drugs and Organics Ltd in the Q2 results 2025 was -14.83%.
The revenue for Mangalam Drugs and Organics Ltd in the Q2 results 2024 was ₹80.08Cr.
The net profit for Mangalam Drugs and Organics Ltd in the Q2 results 2024 was ₹2.69Cr.
The net profit margin for Mangalam Drugs and Organics Ltd in the Q2 results 2024 was 3.36%.